{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Therapy for diabetic complications", "item": "https://www.patentleaderboard.com/patent/5378717"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapy for diabetic complications

Therapy for diabetic complications

US Patent 5378717 · Granted Jan 3, 1995

Estimated economic value: $40,262,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

(Thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity H2017
BACE inhibitors2016
Substituted [(5H-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dime2012
2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-HT7 receptor ant2012
5- [4-(azetidin-3-yloxy)-phenyl]-2-phenyl-5H-thiazolo[5,4-C] pyridin-4-one deriv2011
5-HT7 receptor antagonists2011
1-(hetero)aryl-3-amino-pyrrolidine derivatives for use as mGluR3 antagonists2011
3-Aminopyrrolidines as inhibitors of monoamine uptake2009
Aminomethyl-azacycle derivatives as inhibitors of monoamine uptake2009
Morpholine derivatives as norepinephrine reuptake inhibitors2009
4-Amino-piperidine derivatives as monoamine uptake inhibitors2009
Pyridinylmorpholine derivatives2009